A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A report published...

UPDATE (September 23, 2020): At the end of March, as the severity of the coronavirus pandemic and COVID-19 were becoming increasingly apparent, Johnson & Johnson announced that it expected to be able...

WHO warns of surge in coronavirus cases in Europe EEurope is seeing more weekly coronavirus cases than it did in March’s peak; Amy Kellogg reports. Editors of a highly respected medical journal discussed...

Fox News Flash top headlines for September 18 Medical groups and health organizations have urged the U.S. Food and Drug Administration (FDA) to remain transparent and maintain independent authority when...

A big talking point this past week was the temporary suspension of the Oxford vaccine, one of the most promising under development, due to a potential adverse reaction. This was a real blow to some people...

Adjuvants are a key ingredient of many modern vaccines, working to unleash an immune response that helps protect the body from disease. Many scientists believe that adjuvants are they key to developing...

The halting of clinical trials for one of the most advanced experimental COVID-19 vaccines shows the importance of safety in developing new medicines despite overwhelming international pressure, experts...

An international research network of physicians and scientists is launching a clinical trial to evaluate whether the vaccine for measles, mumps and rubella (MMR) can protect front-line health-care workers...

Johnson & Johnson reveals its coronavirus shot prevents severe illness in hamsters as the drug giant says human trials will start this month Johnson & Johnson tested its coronavirus vaccine candidate,...

With the race on to find a coronavirus vaccine, the biotech sector—from an investor’s point of view—appears to be the new gold rush, promising often giddy returns, but analysts warn that the...